Status:

ENROLLING_BY_INVITATION

Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick

Lead Sponsor:

National Cancer Institute (NCI)

Conditions:

Healthy Donors

Eligibility:

All Genders

18+ years

Brief Summary

Background -NCI-Frederick scientists performing in vitro studies involving human specimens have a need for a reliable and consistent source of samples which protects the donor from research risks. O...

Detailed Description

Background -NCI-Frederick scientists performing in vitro studies involving human specimens have a need for a reliable and consistent source of samples which protects the donor from research risks. O...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Individuals must meet the following eligibility criteria to be entered into the RDP donor pool, as follows:
  • Age 18 or older.
  • Weight of 110 lb or greater.
  • All subjects must have the ability and agree to participate fully and comply with the procedures of the protocol and provide informed consent.
  • Registration for participation in semen donation is limited to males currently enrolled in the donor pool.
  • Subjects must be NCI Frederick Employees
  • EXCLUSION CRITERIA:
  • Individuals with any of the following will be excluded from the donor pool:
  • History of chronic illness that might increase the risks associated with phlebotomy, including but not limited to heart, lung, or kidney disease
  • Current acute illness.
  • History of clotting disorders.
  • Current medications which might increase the risk associated with phlebotomy.
  • History of syncope or other difficulty with venipuncture.
  • Anemia, as determined by hematocrit or hemoglobin.
  • Hematocrit acceptable range for males: 40-51 percent.
  • Hematocrit acceptable range for females: 34-46 percent.
  • Hemoglobin acceptable range for males: 12.5-17.0 g/dl
  • Hemoglobin acceptable range for females: 11.5-15.2 g/dl
  • Positive blood test for exposure to HIV-1, HIV-2, HTLV-1, HTLV-2, or HCV or for HBV surface antigens.
  • Individuals whose activities or conditions place them at high risk of HIV infection are asked not to donate.
  • Males who qualify for participation in the donor pool will be excluded from participation in semen donation if they have knowingly had any injury, infection, or treatment performed that renders them incapable of producing sperm.
  • Pregnancy: Pregnant women will not be allowed to enroll in this study because there is no benefit.

Exclusion

    Key Trial Info

    Start Date :

    November 1 1999

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 13 2030

    Estimated Enrollment :

    1200 Patients enrolled

    Trial Details

    Trial ID

    NCT00339911

    Start Date

    November 1 1999

    End Date

    October 13 2030

    Last Update

    December 24 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    NCI Frederick Cancer Research Center

    Frederick, Maryland, United States, 21702-1201

    Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick | DecenTrialz